换一批
换一批Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
作者：
Riccardo,Bruna [1]
;
Fabio,Benedetti [2]
;
Carola,Boccomini [3]
;
Caterina,Patti [4]
;
Anna Maria,Barbui [5]
;
Alessandro,Pulsoni [6]
;
Maurizio,Musso [7]
;
Anna Marina,Liberati [8]
;
Guido,Gini [9]
;
Claudia,Castellino [10]
;
Fausto,Rossini [11]
;
Fabio,Ciceri [12]
;
Delia,Rota-Scalabrini [13]
;
Caterina,Stelitano [14]
;
Francesco,Di Raimondo [15]
;
Alessandra,Tucci [16]
;
Liliana,Devizzi [17]
;
Valerio,Zoli [18]
;
Francesco,Zallio [19]
;
Franco,Narni [20]
;
Alessandra,Dondi [21]
;
Guido,Parvis [22]
;
Gianpietro,Semenzato [23]
;
Francesco,Lanza [24]
;
Tommasina,Perrone [25]
;
Francesco,Angrilli [26]
;
Atto,Billio [27]
;
Angela,Gueli [1]
;
Barbara,Mantoan [28]
;
Alessandro,Rambaldi [5]
;
Alessandro Massimo,Gianni [29]
;
Paolo,Corradini [1]
;
Roberto,Passera [17]
;
Marco,Ladetto [29]
;
Corrado,Tarella [30]
作者单位：
Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milano.
[1]
Hematology University Division, Verona.
[2]
Hematology Division, Città della Salute Hospital, Torino.
[3]
Hematology Division, Azienda Villa Sofia-Cervello, Palermo.
[4]
Hematology Division, Papa Giovanni XXIII Hospital, Bergamo.
[5]
Department of Cellular Biotechnologies and Hematology, La Sapienza University, Roma.
[6]
Hematology Unit, La Maddalena Hospital, Palermo.
[7]
SC Oncoematologia, Università degli Studi di Perugia.
[8]
Hematology University Division, Ancona.
[9]
Department of Hematology, S. Croce e Carle Hospital, Cuneo.
[10]
Hematology University Division, Monza.
[11]
Hematology Unit HSR, Milano.
[12]
Oncologia Medica, Cancer Institute FPO, IRCCS, Candiolo.
[13]
Hematology Division, Reggio Calabria.
[14]
Hematology Univiversity Division, Catania.
[15]
Division of Hematology, Brescia.
[16]
University Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.
[17]
Hematology Division, S. Camillo Hospital, Roma.
[18]
SC Ematologia AO SS Antonio e Biagio e Cesare Arrigo, Alessandria.
[19]
Hematology University Division, Modena.
[20]
Division of Oncology, Modena.
[21]
Division of Internal Medicine, S. Luigi Hospital, Orbassano.
[22]
Hematology University Division, Padova.
[23]
Hematology Unit, Cremona.
[24]
Hematology University Division, Bari.
[25]
Hematology Division, Pescara.
[26]
Hematology Division, Bolzano.
[27]
Hematology University Division, Città della Salute Hospital, Torino.
[28]
Department of Oncology and Onco-Hematology, University of Milan, Milano.
[29]
Nuclear Medicine Division, Città della Salute Hospital, Torino.
[30]
Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milano corrado.tarella@unimi.it.
[31]
Department of Health Sciences, University of Milan, Milano, Italy.
[32]
主题词
成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);综合疗法(Combined Modality Therapy);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);意大利(Italy);Kaplan-Meiers评估(Kaplan-Meier Estimate);淋巴瘤, 滤泡性(Lymphoma, Follicular);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);预后(Prognosis);比例危险度模型(Proportional Hazards Models);复发(Recurrence);缓解诱导(Remission Induction);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.3324/haematol.2018.209932
PMID
31666344
发布时间
2020-07-13
- 浏览8
Haematologica
Haematologica
2241-2248页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
